

Published by Dokcare Lifesciences | Anti-Infective Division
That consistency is exactly why Ofloxacin 200mg tablets remain one of the highest-volume anti-infective SKUs in the Indian PCD pharma franchise space. For a new distributor, it’s an anchor product. For an existing franchise partner, it’s often the repeat-order driver that keeps business running between the slower-moving specialty molecules. And for those exploring third-party or loan licence manufacturing, it’s a formulation that offers both volume economics and relatively straightforward production requirements.
But here’s where a lot of B2B pharma decisions go sideways — not for lack of demand, but for lack of clarity. Which manufacturer do you trust? What’s the actual price bracket across brands? And how do you build a business around a molecule that has hundreds of players in the market without getting lost in a race to the bottom?
Ofloxacin belongs to the fluoroquinolone class of antibiotics. It works by inhibiting bacterial DNA gyrase and topoisomerase IV — essentially preventing bacteria from replicating and repairing themselves. At 200mg, it’s the most commonly prescribed oral dose for outpatient treatment of mild to moderate bacterial infections.
The reason demand doesn’t spike and crash like some niche molecules is simple — UTIs, respiratory infections, and skin infections don’t go seasonal. GPs prescribe Ofloxacin 200mg throughout the year, across geographies, in urban clinics and rural PHCs alike. For a franchise partner, that kind of demand profile is gold.
While this blog is specifically about the 200mg tablet, it’s worth understanding where it sits in the broader Ofloxacin product family, because a complete portfolio across strengths and combinations significantly increases your revenue per territory.
| Formulation | Composition | Common Use |
|---|---|---|
| Ofloxacin 200mg Tablet | Ofloxacin 200mg | Standard dose for UTI, RTI, STI |
| Ofloxacin 400mg Tablet | Ofloxacin 400mg | Higher dose for severe or systemic infections |
| Ofloxacin + Ornidazole Tablet | Ofloxacin 200mg + Ornidazole 500mg | GI infections, mixed bacterial-parasitic |
| Ofloxacin + Metronidazole Syrup | Ofloxacin 100mg + Metro 200mg | Paediatric GI infections |
| Ofloxacin Eye/Ear Drops | Ofloxacin 0.3% | Ophthalmic and otic bacterial infections |
| Ofloxacin Suspension | Ofloxacin 50–100mg/5ml | Paediatric formulation for systemic use |
Dokcare Lifesciences manufactures across this entire range — from the standard Oglite-200 (Ofloxacin 200mg, 10×10 tablets) all the way to combination suspensions and ophthalmic preparations — so franchise and third-party clients can build a complete Ofloxacin-range portfolio under one roof.
This is the section that directly impacts your sourcing decision. If you’re evaluating PCD franchise or third-party manufacturing partners for Ofloxacin 200mg, what matters isn’t the branded MNC price — it’s what PCD-focused manufacturers charge per box and what MRP flexibility they give you to build your own margin.
Here’s how active PCD companies in India are currently pricing Ofloxacin 200mg (10×10 box = 100 tablets):
| Brand Name | PCD Company | Location Hub | Box Price (10×10) | Pack Type | GMP Status |
|---|---|---|---|---|---|
| Oflosen-200 | Yodley Lifesciences | Panchkula, HR | ₹ 920 | Strip | WHO-GMP |
| Oflosen-200 | Senen Biotech | Panchkula, HR | ₹ 600 | Strip | GMP Certified |
| Flo-200 | Chemo Biological | New Delhi | ₹ 551 | Strip | GMP Certified |
| Oflawok-200 | Stelon Biotech | Baddi, HP | On Request | Alu-Alu / Strip | WHO-GMP |
| Quifix-200 | Cinerea Biotech | Chandigarh | On Request | Strip | GMP Certified |
| HILLFLO-200 | Frisco Hill Pharmacia | Baddi, HP | On Request | Strip | DCGI Approved |
| Mapcin-200 | Aster Medipharm | Jaipur, RJ | On Request | Alu-Alu | GMP Certified |
| Oflox 200 | Algen Exports | New Delhi | ₹ 400 | Alu-Alu | GMP Certified |
| Oglite-200 | Dokcare Lifesciences | Haryana | Contact for Rate | Strip / Alu-Alu | GMP Certified |
All prices are indicative, sourced from publicly available market data (IndiaMart, TradeIndia). Actual franchise/net rates are negotiated and may vary by MOQ, territory, and packaging preference. GST applicable extra.
The Ofloxacin tablet manufacturing base in India is broad, but not uniform in quality. PCD-focused third party manufacturing clusters concentrated in Baddi (HP), Panchkula (HR), Haridwar, Ahmedabad, and Jaipur produce the bulk of the volume that feeds the franchise and third-party market. The quality divide is real:
For a product like Ofloxacin 200mg where repeat prescription is your revenue engine, a single batch recall or prescriber complaint about potency can undo months of territory development.
One thing rarely discussed openly is the actual margin architecture in PCD pharma for a product like Ofloxacin 200mg. Let’s be real about it.
Typical B2B economics for Ofloxacin 200mg (indicative, varies by manufacturer):
| Parameter | Indicative Range |
|---|---|
| Franchise/Trade Price (per 100 tablets, 10×10 box) | ₹ 350 – 550 |
| MRP on box (per 10 tablets × 10 strips) | ₹ 750 – 1,100 |
| Stockist margin | 10–15% |
| Retailer margin | 15–20% |
| Net franchise margin over purchase price | 30–45% (varies by brand tier) |
The margin difference between a low-cost poorly manufactured product and a quality-compliant product at a similar price point is not significant. But the risk difference is enormous. One bad batch, one failed tablet that a prescriber notices, one short expiry shipment — and your territory credibility takes a hit that no discount can repair.
At Dokcare Lifesciences, we price Oglite-200 to keep franchise partners genuinely competitive in their territories while maintaining the manufacturing standards that protect your business long term. Our 10×10 packaging, Alu-Alu blister option, and labeling flexibility for private-label clients give you the tools to position your brand credibly in the ₹75–100+ MRP window.
We’ll keep this section direct because you’re a business person and your time matters.
If you’re building a new anti-infective brand or expanding an existing one, anchoring your portfolio around a quality Ofloxacin 200mg like Oglite-200 gives you a reliable volume driver that your prescriber base already understands and trusts.

Ofloxacin 200mg is an antibiotic used to treat urinary tract, respiratory, gastrointestinal, and skin infections caused by susceptible bacteria.
Yes. Ofloxacin 200mg is a Schedule H drug and should be used only under a doctor’s prescription.
Oglite-200 is manufactured in a GMP-compliant facility with strict quality controls, ensuring reliable efficacy and safety.
Most Ofloxacin 200mg tablets have a shelf life of 24–36 months when stored in a cool, dry place.
MOQ varies depending on franchise or third-party manufacturing requirements and can be customized based on business needs.
Yes. Dokcare Lifesciences offers private-label and third-party manufacturing services for Ofloxacin 200mg tablets.
Yes. Along with Oglite-200, Dokcare offers combinations such as Ofloxacin + Ornidazole and other anti-infective formulations.